Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Online News Reports.
Press releases published on May 8, 2025

No Tickets, No Hassle, Just Fun with Summertime Sunkissed Vacations
St. Augustine, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Florida’s Historic Coast is offering stress-free adventures with a selection of exclusive offers from lodging and attractions designed for those who are just a stone’s throw away. Rediscover the sunshine …

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights
- Sharpened product candidate focus on its next-generation ADC portfolio, following strategic review and pipeline reprioritization - - Promising preclinical results with STRO-004 and dual-payload ADC, as well as STRO-006 programs presented at AACR 2025 and …

17th Gulf Heart Association Conference
17th Gulf Heart Association Conference, November 20-22, Doha, Qatar DOHA, QATAR, May 8, 2025 /EINPresswire.com/ -- The Gulf Heart Association (GHA) is excited to announce the upcoming 17th GHA Conference, set to be held in Doha, Qatar from November 20th …

Automotive Gudgeon Pin Market to Reach USD 5.94 Billion by 2035 Amid Rising Demand for High-Performance ICE Components
Automotive Gudgeon Pin Market to grow steadily by 2035, driven by rising engine efficiency demands and lightweight component adoption. NEWARK, DE, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- The automotive gudgeon pin market is poised for steady …

Hepsiburada Announces First Quarter 2025 Financial Results
ISTANBUL, May 08, 2025 (GLOBE NEWSWIRE) -- D-MARKET Electronic Services …

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANN ARBOR, Mich., May 08, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on May 7, 2025, the Company granted 15 new employees 49,300 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan. The 2017 …

Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets
Pre-NDA Meeting for CTx-1301(dexmethylphenidate) Held April 2, 2025; New Drug Application Submission Targeted for Mid-2025 Non-Dilutive Funding to Accelerate Development of CTx-2103 (buspirone) KANSAS CITY, Kan., May 08, 2025 (GLOBE NEWSWIRE) -- Cingulate …

BioSyent Schedules First Quarter Earnings Release for May 15, 2025
MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2025 on Thursday, May 15, 2025 after market hours. A presentation …

Galecto Reports First Quarter 2025 Operating and Financial Results
BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter …

Montauk Renewables Announces First Quarter 2025 Results
PITTSBURGH, May 08, 2025 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery, and conversion of biogas into renewable natural gas (“RNG”), today …

BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
MELVILLE, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced …

U.S. Energy Corp. Announces First Quarter 2025 Results Conference Call Date
HOUSTON, May 08, 2025 (GLOBE NEWSWIRE) -- U.S. Energy Corporation (NASDAQ: USEG, “U.S. Energy” or the “Company”), a growth-focused energy company engaged in the development and operation of high-quality producing energy and industrial gas assets, today …

Southside Bancshares, Inc. Declares Cash Dividend
TYLER, Texas, May 08, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Southside Bancshares, Inc., (NYSE:SBSI), parent company of Southside Bank declared a regular quarterly cash dividend of $0.36 per common share. The cash dividend of $0.36 is scheduled …

Theriva Biologics Announces Closing of $7.5 Million Public Offering
ROCKVILLE, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, …

Now Open: Iowa Behavioral Associates Accepting Patients Statewide
Now open in West Des Moines, Iowa Behavioral Associates is accepting new patients and offering expert care for anxiety, depression, PTSD, and more. WEST DES MOINES, IA, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- Iowa Behavioral Associates (IBA) is …

17th Gulf Heart Association Conference
DOHA, QATAR, May 8, 2025 /EINPresswire.com/ -- مايو 20258 مؤتمر جمعية القلب الخليجية السابع عشر الدوحة، قطر – يسرّ جمعية القلب الخليجية (GHA) أن تعلن عن انطلاق مؤتمرها في نسخته السابعة عشرة. ومن المزمع انعقاد المؤتمر في الدوحة، قطر، خلال الفترة من 20 …

EnGarde® body armor Partners with TacSource to Expand Distribution in Australia and New Zealand
AMSTERDAM, NH, NETHERLANDS, May 8, 2025 /EINPresswire.com/ -- EnGarde® body armor, a global leader in advanced ballistic protection solutions, is pleased to announce a new partnership with TacSource Group, a premier tactical gear supplier in Australia …

Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
On track for first patient dosing of SER-252 in Phase 1b clinical trial in advanced Parkinson’s disease in Q4 2025 Strengthened balance sheet with recent financing Advancing innovative POZ Platform across multiple therapeutic modalities Two new seasoned …

Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
RESEARCH TRIANGLE PARK, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2025 financial results …

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
Data cutoff date for Phase 2b NAVIGATE trial efficacy reached on April 30, 2025; top-line data readout expected in late June 2025 Nature Microbiology publication highlights preclinical data and the potential of CD388 as a potent, universal antiviral for …